Bone Tumor, Lung Tumor, Renal Tumor
Conditions
Brief summary
The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation in the treatment of malignant bone, lung and renal tumors.
Interventions
DEVICEMicrowave ablation with Acculis Accu2i pMTA Applicator
Sponsors
Centre Hospitalier Universitaire de Besancon
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Men and women \> 18 years old * Thermoablation indication of renal neoplasia, bone or lung decided during a multidisciplinary consultation meeting - Generally speaking, the indications are: (i) inoperable primary malignant tumor or secondary malignant tumor, (ii) resectable primary malignant renal and lung tumor with medical contraindication to surgery or general anesthesia * Signature of informed consent for participation * Affiliation to a social security scheme or French beneficiary of such a regime.
Exclusion criteria
* Contraindication to percutaneous thermoablation * Renal or lung tumor up to 4 cm * Women of childbearing age, premenopausal, non-sterilized surgically, and unwilling to use effective contraception * Legal incapacity or legal capacity limited * Person unlikely to cooperate in the study and / or low degree of cooperation expected by the investigator * Person without health insurance * Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor necrosis rate in post-intervention over one month monitoring period. | one month |
Countries
France
Outcome results
None listed